The Healthcare & Pharma Consulting Market in 2024
Growth in the healthcare & pharma consulting market is forecast to rise 8% in 2024. Against this promise of healthy market recovery, Source’s Healthcare & Pharma Consulting Market Trends report sets out the top opportunities for firms.
“Clients view technology solutions as an essential tool for improving their operational productivity and identified the need to transform their technology as the most important reason their use of consultants would increase. As a result, firms can expect significant tech-related opportunities in the healthcare and pharma space.” Emily Whittingham, Source.
Underpinned by our MegaModel and our annual survey of 100 senior buyers of consulting in the healthcare & pharma market, this report delivers an independent and objective understanding of the state of play. It is full of must-have data and insight for firms looking to succeed in the market.
You will gain access to:
- A snapshot of what really matters and where Source analysts think the opportunities are.
- An overview of the market, which grew 3.7% in 2023 to hit $2.6bn.
- A review of client priorities, including a rising interest in improving customer experience.
- The key implications for your firm, including exploring the importance of showcasing relevant expertise.
- Insight from consulting firms who are operating in this market today.
To find out more, download the report or contact us.